USPTO serial 79059325
PLASMIDAMP
Reviewed by CopyMark Law Group
Reg. 3767554Status 404
- Filing date
- Status date
- Registration date
- Mar 30, 2010
- Examiner
- POLZER, NATALIE M
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with PLASMIDAMP?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Gary D. Krugman
Gary D. Krugman Sughrue Mion PLLC2100 Pennsylvania Avenue, N.W.Suite 800Washington, DC 20037Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical, biochemical and biotechnological products for industrial and scientific purposes and for laboratory analyses, namely, nucleic acids, enzymes and polymerases for laboratory and research use, reagents and buffers used for the isolation, purification or separation of nucleic acids, oligonucleotides or proteins, none of the foregoing for medical or veterinary purposes; reagents and solvents for sample preparation, modification and manipulation of cells and for conducting marking, separating, isolating, purifying, amplification and/or analytic methods for natural and synthetic biopolymers, namely, nucleic acids, oligonucleotides, proteins, macromolecules and biologically active substances; kits comprising chemicals for sample preparation, modification and manipulation of samples and cells and kits comprising chemicals for marking, separating, isolating, purifying, amplifying and/or for the chemical and scientific analysis of natural and synthetic biopolymers, namely, nucleic acids, oligonucleotides, proteins, macromolecules and biologically active substances, kits comprising chemicals and reagents for isolating nucleic acids | SECTION 71 - CANCELLED | — |
| 005 | Pharmaceutical and veterinary preparations for health care, namely, nucleic acids, chemical reagents and biochemical preparations; diagnostic preparations for medical purposes; diagnostic preparations for medical and veterinary purposes, namely, diagnostic preparations for sample preparation, modification and manipulation of samples and cells and diagnostic preparations for marking, separating, isolating, purifying, amplification and/or medical and veterinary analysis of biopolymers, namely, nucleic acids, oligonucleotides, proteins, macromolecules and biologically active substances; chemical, biochemical and biotechnological preparations for medical use, namely, medical and veterinary diagnostic reagents and solvents for sample preparation, modification and manipulation of samples and cells and medical and veterinary diagnostic reagents and solvents for conducting marking, separating, isolating, purifying, amplifying and/or analysis methods for biopolymers, namely, nucleic acids, proteins, macromolecules and biologically active substances for diagnostic purposes; kits containing diagnostic preparations for medical and veterinary diagnostic purposes; in vitro diagnostics reagents for medical purposes, kits comprising diagnostic preparations for medical or veterinary purposes, namely, for medical and veterinary sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, amplification and/or for the analysis of biopolymers, namely, nucleic acids, oligonucleotides, proteins, macromolecules and biologically active substances; all purpose disinfectants | SECTION 71 - CANCELLED | — |
| 009 | Scientific apparatus, instruments and equipment; namely, surveying, weighing, measuring, signalling and regulating apparatus, instruments and devices for research, laboratory and analysis purposes, namely, disposable laboratory articles, scales, plastic, sample storage, reaction and collection vessels, plates and multi-well plates that can be used in chemical analysis, biological analysis or patterning for scientific, laboratory or medical research use, pipette tips, namely, filter tips and dispenser tips, pipette tips and carrying pipette tip boxes, laboratory storage and test tubes, micro-tubes and tubes for polymerase chain reaction (PCR), micro laboratory centrifuges and laboratory micro-injectors, capillaries, cuvettes, spin columns, chromatography columns and cartridges for scientific or laboratory use which utilize chromatographic material for the separation, purification, and isolation of biopolymers, nucleic acids, oligonucleotides, proteins, macromolecules and biologically active substances from sample material; racks and holders for sample storage beakers, tubes, syringes and pipette tips; magnetic beads, filter membranes and devices comprising silica material for isolation and purification of nucleic acid and oligonucleotides, as well as for isolation and purification of other biological materials, for laboratory and scientific use; sample presentation devices, namely, laboratory research microarrays, chips, used for laboratory or medical research; matrix-assisted laser desorption/ionization (MALDI) presentation devices, namely, laser desorption plates for use in analytical analysis; laboratory robots, operation robots and robotic workstations comprising computer hardware for laboratory robots; laboratory incubators for diagnostic, clinical and research applications for the preparation, modification, isolation, crystallization, handling, amplification and manipulation of samples and for the marking, separation, isolation, purification, reproduction and analysis of biopolymers, nucleic acids, oligonucleotides, proteins, macromolecules and biologically active substances from sample material; laboratory apparatus and equipment for dosage, dispensing, transferring, temperature equalizing, agitating, mixing, diluting, concentrating and separating of liquids, namely, calipers and machines for dispensing pre-determined amounts of liquids; matrix-assisted laser desorption/ionization (MALDI) plates for us in analytical analysis, medical, diagnostic and research workstations comprised of computer hardware and software for reading and handling multi-well plates for the analysis of biopolymers, nucleic acids, oligonucleotides, proteins, macromolecules and biologically active substances from sample material cyclers, thermocyclers, lysis apparatus, disrupters, physico-chemical, bio-chemical, optical and electronic analysis apparatus and equipment, namely, photometers, spectrophotometers, optical scanners for detection of fluorescence and colorimetric signals; apparatus and instruments for processing cells or liquids containing cell material, namely, electroporators, electrofusion apparatus, micro injectors and micro manipulators; vacuum chambers for chromatography, purification, separation and characterization of natural and synthetic biopolymers, nucleic acids, oligonucleotides, proteins, macromolecules and biologically active substances from sample material; centrifuges for laboratory use; vacuum systems comprised of vacuum manifold and vacuum tube emulators for laboratory use, vacuum concentrators, centrifugal concentrators, rotors for laboratory centrifuges and vacuum concentrators; mixers for laboratory use; mechanical, electronic and automatic pipettes and dispensers | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by QIAGEN GmbH
- Other trademarks owned by QIAGEN GmbH
- Other trademarks owned by QIAGEN GmbH
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Similar marks named PLASMIDAMP
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 29, 2018 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED | — |
| Jun 29, 2018 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Aug 4, 2017 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Jul 6, 2017 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Jul 6, 2017 | INPC | INVALIDATION PROCESSED | — |
| Jul 4, 2017 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Nov 4, 2016 | C71T | CANCELLED SECTION 71 | — |
| Dec 14, 2013 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 5, 2013 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jul 15, 2010 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jul 15, 2010 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jun 30, 2010 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Apr 9, 2010 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Mar 30, 2010 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 25, 2010 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 25, 2010 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jan 12, 2010 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 12, 2010 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 7, 2009 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Dec 4, 2009 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 4, 2009 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Dec 4, 2009 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Dec 4, 2009 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Dec 4, 2009 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 9, 2009 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 9, 2009 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 9, 2009 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 3, 2009 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| May 31, 2009 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| May 20, 2009 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| May 15, 2009 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 5, 2009 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 5, 2009 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 4, 2009 | ALIE | ASSIGNED TO LIE | — |
| May 1, 2009 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 1, 2009 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 1, 2009 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 28, 2008 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 3, 2008 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 3, 2008 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 1, 2008 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 31, 2008 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 28, 2008 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 24, 2008 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 24, 2008 | NWAP | NEW APPLICATION ENTERED | — |
| Oct 23, 2008 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |